Departamento de Medicina Interna, Hospital Universitario Puerta de Hierro, Madrid, Spain.
Biostatistics Unit, Puerta de Hierro Biomedical Research Institute (IDIPHISA), CIBERESP, Madrid, Spain.
Transplant Proc. 2021 Dec;53(10):2826-2832. doi: 10.1016/j.transproceed.2021.09.047. Epub 2021 Nov 10.
There is limited knowledge about risk factors for Clostridioides difficile infection (CDI) and recurrent CDI in solid organ transplant (SOT) recipients.
A case-control study of CDI in SOT recipients compared with controls (SOT recipients who did not present CDI).
Sixty-seven patients from 1089 SOT recipients (6.2%) suffered at least one episode of CDI. The mean age was 55 ± 12 years and 20 cases (69%) were men. The accumulated incidence was 8% in liver transplantation, 6.2% in lung transplantation, 5.4% in heart transplantation, and 4.7% in kidney transplantation. Twenty-nine cases (43.3%) were diagnosed during the first 3 months after SOT. Forty-one cases (61.2%) were hospital acquired. Thirty-one patients with CDI presented with mild-moderate infection (46.3%), 30 patients with severe infection (44.8%), and 6 patients with severe-complicated disease (9%). Independent variables found to be related with CDI were hospitalization in the previous 3 months (odds ratio: 2.99; [95% confidence interval 1.21-7.37]) and the use of quinolones in the previous month (odds ratio: 3.71 [95% confidence interval 1.16-11.8]). Eleven patients (16.4%) had at least one recurrence of CDI. Previous treatment with amoxicillin-clavulanate, severe-complicated index episode, and high serum creatinine were associated with recurrent CDI in the univariant analysis CONCLUSIONS: Liver transplant recipients presented the highest incidence of CDI among SOT recipients. Risk factors for CDI were hospitalization in the previous 3 months and the use of quinolones in the previous month.
对于实体器官移植(SOT)受者的艰难梭菌感染(CDI)和复发性 CDI,相关知识有限。
对 SOT 受者的 CDI 病例对照研究,将其与对照(未出现 CDI 的 SOT 受者)进行比较。
在 1089 名 SOT 受者中,有 67 名(6.2%)至少发生过一次 CDI。平均年龄为 55 ± 12 岁,20 例(69%)为男性。肝移植的累积发病率为 8%,肺移植为 6.2%,心脏移植为 5.4%,肾脏移植为 4.7%。29 例(43.3%)在 SOT 后 3 个月内确诊。41 例(61.2%)为医院获得性感染。31 例 CDI 患者感染程度为轻中度(46.3%),30 例为重度感染(44.8%),6 例为重度合并症(9%)。与 CDI 相关的独立变量为前 3 个月住院(优势比:2.99;[95%置信区间 1.21-7.37])和前 1 个月使用喹诺酮类药物(优势比:3.71[95%置信区间 1.16-11.8])。11 例(16.4%)至少有一次 CDI 复发。单变量分析中,阿莫西林克拉维酸治疗史、重度合并症指数发作和高血清肌酐与复发性 CDI 相关。
肝移植受者的 CDI 发生率在 SOT 受者中最高。CDI 的危险因素是前 3 个月住院和前 1 个月使用喹诺酮类药物。